DEA Archived Press Releases

Press Releases before January 20, 2025
5 Results - Showing 1 to 5
PRESS RELEASE

Two MS-13 Leaders Convicted of Racketeering Conspiracy and Conspiring to Commit Multiple Murders

Washington, D.C. - Yesterday, a federal jury in Maryland convicted two El Salvadorian nationals for conspiring to participate in La Mara Salvatrucha, a transnational criminal enterprise, commonly known as MS-13. Junior Noe Alvarado-Requeno, aka Insolente, aka Trankilo, 25, and Miguel Angel Corea Diaz, aka Reaper, 39, were convicted of multiple...
PRESS RELEASE

DEA, DOD, DHS and U.S. Coast Guard announce offload of more than 33,000 pounds of seized drugs in Fort Lauderdale

FORT LAUDERDALE, Fla. – The Drug Enforcement Administration, Department of Defense, and Department of Homeland Security, and U.S. Coast Guard announced today a significant offload of drugs seized in international waters in the Eastern Pacific Ocean and Caribbean Sea. Agents with the DEA and the crew of the USCG Cutter...
PRESS RELEASE

DEA proposes process to expand marijuana research in the United States

WASHINGTON – Today, the Drug Enforcement Administration and the Department of Justice announced action to further expand opportunities for scientific and medical research on marijuana in the United States. The Notice of Proposed Rulemaking provides details on the proposed process and was filed for public inspection today, March 20. The...
PRESS RELEASE

Vice President attends $569 million cocaine offload in Coronado

CORONADO , Calif. – On July 11, 2019, Vice President Mike Pence, Office of National Drug Control Policy Director James W. Carroll, Drug Enforcement Administration Acting Administrator Uttam Dhillon, and Vice Admiral Linda Fagan, commander of Coast Guard Pacific Area, attended a United States Coast Guard drug offload at Naval...
PRESS RELEASE

FDA-approved drug Epidiolex placed in schedule V of Controlled Substance Act

WASHINGTON - The Department of Justice and Drug Enforcement Administration today announced that Epidiolex, the newly approved medication by the Food & Drug Administration, is being placed in schedule V of the Controlled Substances Act, the least restrictive schedule of the CSA. In June 2018, the FDA announced it approved...